There is some evidence of reduced ERBB4 expression in the immune cells of patients with MS, suggesting that this protein is involved in the proliferation of oligodendrocyte progenitor cells, the differentiation of oligodendrocytes and remyelination (Tynyakov-Samra et al. 2011). This evidence concerns the gene ERBB4 and myeloid sarcoma.